COPD emerged as an umbrella term for several respiratory diseases, including emphysema and chronic bronchitis, caused by lung damage. Because its effects are irreversible, early diagnosis and ...

Your mouth's health significantly impacts your entire body, new research reveals. Poor oral hygiene is linked to serious ...

People tend to worry about lifestyle diseases like diabetes, hypertension, obesity and joint pain. Very few people give their gums a thought unless they hurt or bleed. Yet, healthy gums are vital for ...

Severe COPD exacerbations are pivotal for both respiratory decline and cardiovascular vulnerability, with increased medication use post-exacerbation. Cardiovascular events occurred in 18.5% of ...

Even if you’re diligent about caring for your teeth, you might be overlooking your gums. By Jancee Dunn For years, I have brushed my teeth with a little too much gusto — as if I were scrubbing ...

Among adolescents, the presentation of obstructive sleep apnea syndrome (OSAS) mirrors many typical signs of a much more common age-related diagnosis — hyperactivity, decreased attention span and ...

It's common knowledge that avoiding too much sugar or acid-containing foods is a good way to keep your oral health on the right track. But a new study now reveals that a common well-regarded eating ...

COPD affects at least 4.5% of those 18-49 years old, according to an analysis of U.S. cohorts. The early COPD group was more likely to be hospitalized or die from chronic respiratory disease, to ...

Roche’s hopes of getting its chronic obstructive pulmonary disease (COPD) drug astegolimab to regulators this year have taken a hit after the anti-ST2 monoclonal antibody failed to reduce flare-ups in ...

Blood in the sink after brushing teeth sends immediate alarm signals through most people’s minds. The sight of pink-tinged saliva or red streaks on dental floss creates instant concern about oral ...

The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease (COPD), Sanofi and Regeneron announced on Friday. An injectable interleukin ...